The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Prognostic value of cytokines and chemokines in addition to the GRACE Score in non-ST-elevation acute coronary syndromes
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“no previous studies to date have demonstrated such a promising prognostic relevance for increased IL-1β levels with worsening outcomes in coronary artery disease47, 49–51.”
From Rac2 Modulates Atherosclerotic Calcification by Regulating Macrophage Interleukin-1β Production (2017) · cites this paper as [47]
In the citing paper
“Few clinical studies have measured IL-1β levels and successfully demonstrated a direct association with atherosclerotic burden much less atherosclerotic calcification or outcomes47–49.”
From Rac2 Modulates Atherosclerotic Calcification by Regulating Macrophage Interleukin-1β Production (2017) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Delves, P. J., & Roitt, I. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007063430107 · Cited by 1,666
Clinical Efficacy of an Automated High-Sensitivity C-Reactive Protein Assay
Rifai, N., Tracy, R. P., & Ridker, P. M. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.12.2136 · Cited by 613
Research works printed but not linked: 32
- Yan, 2009, Understanding physicians' risk stratification of acute coronary syndromes: insights from the Canadian ACS 2 Registry, Arch Intern Med, 169, 372, 10.1001/archinternmed.2008.563 · DOI
- de Araujo, 2005, TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS, Eur Heart J, 26, 865, 10.1093/eurheartj/ehi187 · DOI · Paper page
- Yan, 2007, Risk scores for risk stratification in acute coronary syndromes: useful but simpler is not necessarily better, Eur Heart J, 28, 1072, 10.1093/eurheartj/ehm004 · DOI · Paper page
- Armstrong, 2006, Inflammatory biomarkers in acute coronary syndromes: part I: introduction and cytokines, Circulation, 113, e72
- Pearson, 2003, Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association, Circulation, 107, 499, 10.1161/01.CIR.0000052939.59093.45 · DOI · Paper page
- O'Donoghue, 2008, The future of biomarkers in the management of patients with acute coronary syndromes, Curr Opin Cardiol, 23, 309, 10.1097/HCO.0b013e3283021b24 · DOI
- Correia, 2007, Does high-sensitivity C-reactive protein add prognostic value to the TIMI-Risk Score in individuals with non-ST elevation acute coronary syndromes?, Clin Chim Acta, 375, 124, 10.1016/j.cca.2006.06.026 · DOI
- Apple, 2003, Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology Consensus Recommendations, Clin Chem, 49, 1331, 10.1373/49.8.1331 · DOI · Paper page
- Granger, 2003, Predictors of hospital mortality in the global registry of acute coronary events, Arch Intern Med, 163, 2345, 10.1001/archinte.163.19.2345 · DOI · Paper page
- Chen, 1999, Simultaneous quantification of six human cytokines in a single sample using microparticle-based flow cytometric technology, Clin Chem, 45, 1693, 10.1093/clinchem/45.9.1693 · DOI · Paper page
- Spinas, 1992, Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia, J Clin Invest, 90, 533, 10.1172/JCI115891 · DOI · Paper page
- Pencina, 2008, Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond, Stat Med, 27, 157, 10.1002/sim.2929 · DOI · Paper page
- Kraaijeveld, 2007, CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms, Circulation, 116, 1931, 10.1161/CIRCULATIONAHA.107.706986 · DOI
- de Jager, 2008, CCL3 (MIP-1 alpha) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events, J Mol Cell Cardiol, 45, 446, 10.1016/j.yjmcc.2008.06.003 · DOI
- de Lemos, 2003, Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes, Circulation, 107, 690, 10.1161/01.CIR.0000049742.68848.99 · DOI · Paper page
- Kervinen, 2004, Prognostic usefulness of plasma monocyte/macrophage and T-lymphocyte activation markers in patients with acute coronary syndromes, Am J Cardiol, 94, 993, 10.1016/j.amjcard.2004.06.052 · DOI
- de Lemos, 2007, Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial, J Am Coll Cardiol, 50, 2117, 10.1016/j.jacc.2007.06.057 · DOI · Paper page
- Jaremo, 2008, Interleukin-6 and neutrophils are associated with long-term survival after acute myocardial infarction, Eur J Intern Med, 19, 330, 10.1016/j.ejim.2007.06.017 · doi:10.1016/j.ejim.2007.06.017
- Malarstig, 2008, Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome, Heart, 94, 724, 10.1136/hrt.2007.119271 · DOI
- Tziakas, 2007, Inflammatory and anti-inflammatory variable clusters and risk prediction in acute coronary syndrome patients: a factor analysis approach, Atherosclerosis, 193, 196, 10.1016/j.atherosclerosis.2006.06.016 · DOI
- Chalikias, 2007, Interleukin-18/interleukin-10 ratio is an independent predictor of recurrent coronary events during a 1-year follow-up in patients with acute coronary syndrome, Int J Cardiol, 117, 333, 10.1016/j.ijcard.2006.05.017 · DOI
- Kavsak, 2007, Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-terminal pro-brain natriuretic peptide, Clin Chem, 53, 2112, 10.1373/clinchem.2007.090613 · DOI
- Hartford, 2007, C-reactive protein, interleukin-6, secretory phospholipase A2 group IIA and intercellular adhesion molecule-1 in the prediction of late outcome events after acute coronary syndromes, J Intern Med, 262, 526, 10.1111/j.1365-2796.2007.01862.x · DOI
- Kilic, 2006, Relation between proinflammatory to anti-inflammatory cytokine ratios and long-term prognosis in patients with non-ST elevation acute coronary syndrome, Heart, 92, 1041, 10.1136/hrt.2005.080382 · DOI · Paper page
- Lee, 2005, Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes, Blood, 105, 526, 10.1182/blood-2004-03-1106 · DOI · Paper page
- Heeschen, 2003, Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes, Circulation, 107, 2109, 10.1161/01.CIR.0000065232.57371.25 · DOI · Paper page
- Rallidis, 2002, Prognostic value of C-reactive protein, fibrinogen, interleukin-6, and macrophage colony stimulating factor in severe unstable angina, Clin Cardiol, 25, 505, 10.1002/clc.4960251106 · DOI
- Anguera, 2002, Elevation of serum levels of the anti-inflammatory cytokine interleukin-10 and decreased risk of coronary events in patients with unstable angina, Am Heart J, 144, 811, 10.1067/mhj.2002.124831 · DOI
- Koukkunen, 2001, C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris, Ann Med, 33, 37, 10.3109/07853890109002058 · DOI · Paper page
- Biasucci, 1999, Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events, Circulation, 99, 2079, 10.1161/01.CIR.99.16.2079 · DOI · Paper page
- Libby, 2002, Inflammation and atherosclerosis, Circulation, 105, 1135, 10.1161/hc0902.104353 · DOI · Paper page
- Aukrust, 2008, Chemokines and cardiovascular risk, Arterioscler Thromb Vasc Biol, 28, 1909, 10.1161/ATVBAHA.107.161240 · DOI · Paper page
Cited by
Targeting Interleukin-1 in Heart Disease
Van Tassell, B. W., Toldo, S., Mezzaroma, E., & Abbate, A. (2013) · Circulation · doi:10.1161/circulationaha.113.003199 · Cited by 302
Byrne, M. L., O’Brien-Simpson, N. M., Reynolds, E. C., Walsh, K. A., Laughton, K., Waloszek, J. M., Woods, M. J., Trinder, J., & Allen, N. B. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.08.010 · Cited by 144
Rac2 Modulates Atherosclerotic Calcification by Regulating Macrophage Interleukin-1β Production
Ceneri, N., Zhao, L., Young, B. D., Healy, A., Coskun, S., Vasavada, H., Yarovinsky, T. O., Ike, K., Pardi, R., Qin, L., et al. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.308507 · Cited by 124
Metadata
- Authors
- Correia, L. C. L., Andrade, B. B., Borges, V. M., Clarêncio, J., Bittencourt, A. P., Freitas, R., Souza, A. C., Almeida, M. C., Leal, J., Esteves, J. P., & Barral-Netto, M.
- Venue
- Clinica Chimica Acta
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 411
- Issue
- 7-8
- Pages
- 540-545
- ISSN
- 0009-8981
- Cited by
- 51
- References
- 2
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prognostic value of cytokines and chemokines in addition to the GRACE Score in non-ST-elevation acute coronary syndromes. https://app.cochat.ai/papers/10.1016/j.cca.2010.01.011
- The paper
- Correia, L. C. L., Andrade, B. B., Borges, V. M., Clarêncio, J., Bittencourt, A. P., Freitas, R., Souza, A. C., Almeida, M. C., Leal, J., Esteves, J. P., & Barral-Netto, M. (2010). Prognostic value of cytokines and chemokines in addition to the GRACE Score in non-ST-elevation acute coronary syndromes. Clinica Chimica Acta. https://doi.org/10.1016/j.cca.2010.01.011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.